{"DataElement":{"publicId":"6060080","version":"1","preferredName":"Secondary Gleason Pattern Assessment Grade Code","preferredDefinition":"A numeric coded response used to determine the score of the second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen which is derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977.","longName":"6063631v1.0:6060077v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6063631","version":"1","preferredName":"Secondary Gleason Pattern Assessment","preferredDefinition":"The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns._The final result of a determination of the value, significance, or extent of.","longName":"6063629v1.0:2465182v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6063629","version":"1","preferredName":"Secondary Gleason Pattern","preferredDefinition":"The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.","longName":"C48604","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Gleason Pattern","conceptCode":"C48604","definition":"The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4969D-59D0-46D4-E053-F662850A8F09","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4969D-59DE-46D4-E053-F662850A8F09","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-01","changeDescription":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6060077","version":"1","preferredName":"Gleason Prostate Cancer Grade Code","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6060077v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Gleason Pattern 1","ValueMeaning":{"publicId":"2925235","version":"1","preferredName":"Gleason Pattern 1","longName":"2925235","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 1","conceptCode":"C28085","definition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C13D-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-625D-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"2","valueDescription":"Gleason Pattern 2","ValueMeaning":{"publicId":"2925236","version":"1","preferredName":"Gleason Pattern 2","longName":"2925236","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 2","conceptCode":"C28086","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C15F-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-6269-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"3","valueDescription":"Gleason Pattern 3","ValueMeaning":{"publicId":"2925237","version":"1","preferredName":"Gleason Pattern 3","longName":"2925237","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 3","conceptCode":"C28087","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C181-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-6275-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"4","valueDescription":"Gleason Pattern 4","ValueMeaning":{"publicId":"2925238","version":"1","preferredName":"Gleason Pattern 4","longName":"2925238","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 4","conceptCode":"C28088","definition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1A3-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-6281-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"5","valueDescription":"Gleason Pattern 5","ValueMeaning":{"publicId":"2925239","version":"1","preferredName":"Gleason Pattern 5","longName":"2925239","preferredDefinition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 5","conceptCode":"C28089","definition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1C5-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-628D-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"99","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"647BB9FD-6297-0A7A-E053-F662850A91F4","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BB9FD-6242-0A7A-E053-F662850A91F4","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-03-01","changeDescription":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3314494","version":"1","longName":"Labs","context":"ECOG-ACRIN"},{"publicId":"10000047","version":"1","longName":"Pathology","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Gleason grade, secondary","type":"Preferred Question Text","description":"Gleason grade, secondary","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BF251-4586-0A74-E053-F662850A3FBE","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeDescription":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}